首页> 美国卫生研究院文献>other >Posterolateral decompression bone graft fusion posterior instrumentation and local continuous chemotherapy in the surgical treatment of thoracic spinal tuberculosis
【2h】

Posterolateral decompression bone graft fusion posterior instrumentation and local continuous chemotherapy in the surgical treatment of thoracic spinal tuberculosis

机译:后外侧减压植骨融合后路器械和局部连续化疗在胸椎结核治疗中的应用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

To investigate the clinical efficacy of surgical treatment for thoracic spinal tuberculosis with kyphosis deformity via posterolateral debridement, fusion, posterior instrumentation and local continuous chemotherapy. A total of 25 patients with thoracic tuberculosis received surgery by posterolateral decompression, fusion, posterior instrumentation, and postural drainage with local continuous chemotherapy between June 2009 and October 2011. The clinical outcomes was evaluated using statistical analysis about deformity correction, bone fusion, neurologic status, and the visual analog score (VAS) and erythrocyte sedimentation rate (ESR). All of 25 patients were followed up for 39.0 ± 10.7 months (range, 24–60 months) postoperatively. There was no recurrence of tuberculosis, breakage and looseness of internal fixation. Bony fusion was achieved in all cases with 6.7 ± 1.9 months. The values of ESR recovered to normal within 6 months postoperatively. All patients with neurological deficit had significant improvement at the final follow-up. The average preoperative Cobb angles were significantly decreased to 12.2 ± 2.9° (range, 8–17°) postoperatively, and at final follow-up were 12.9 ± 2.7°. Our results showed that single-stage posterolateral debridement fusion, posterior instrumentation and local continuous chemotherapy can be expected to yield satisfactory clinical and radiographic outcomes in patients with thoracic spinal tuberculosis.
机译:目的探讨通过后外侧清创,融合,后路器械和局部连续化疗对胸椎后凸畸形的胸椎结核进行手术治疗的临床疗效。 2009年6月至2011年10月之间,共有25例胸椎结核患者接受后外侧减压,融合,后路器械和体位引流,并接受局部连续化疗。通过对畸形矫正,骨融合,神经系统状况的统计分析,对临床结果进行评估,以及视觉模拟评分(VAS)和红细胞沉降率(ESR)。术后25例均获随访,随访时间39.0±10.7个月(范围24-60个月)。没有结核复发,内固定物破裂和松动。所有病例均在6.7±1.9个月内达到骨融合。术后6个月内ESR值恢复正常。在最后的随访中,所有神经功能缺损的患者均有明显改善。术前平均Cobb角术后明显降低至12.2°±2.9°(范围8–17°),最终随访时为12.9°±2.7°。我们的研究结果表明,单期后外侧清创术融合,后路器械和局部连续化疗有望为胸椎结核患者带来令人满意的临床和影像学结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号